OR WAIT null SECS
March 20, 2013
Bristol-Myers Squibb embarks on a multi-year journey to overcome the challenges of serialization and reap the benefits.
March 12, 2013
INTERPOL and 29 of the world’s largest pharmaceutical companies have joined forces in an initiative to battle counterfeit drugs.
March 02, 2013
As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
February 20, 2013
Equipment purchased today for the packaging line should be serialization-ready in preparation for upcoming requirements.
February 02, 2013
Medication safety and efficacy depend on maintaining products at the proper temperature.
Protecting patients from counterfeit medicines is a pressing issue facing governments and the pharmaceutical industry.
January 16, 2013
Advances in data loggers and radio-frequency identification tags help meet the increasing need for managing the pharmaceutical cold chain.
December 02, 2012
As the battle against counterfeits gains momentum, PharmTech speaks to Mark Davison, CEO of Blue Sphere Health, and Craig Stobie, global life sciences sector manager at Domino Printing Sciences, about the challenges involved.
In addition to globalisation, high financial rewards and low penalties for counterfeiters are contributing to the rise in fake medicines.
Adeline Siew PharmTech speaks to Lynne Byers and Brian Johnson about Rx-360's initiatives to protect patient safety.